Invention Grant
US07648991B2 Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
有权
反式-1 - （（1R，3S）-6-氯-3-苯基茚满-1-基）-3,3-二甲基哌嗪的结晶基
- Patent Title: Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
- Patent Title (中): 反式-1 - （（1R，3S）-6-氯-3-苯基茚满-1-基）-3,3-二甲基哌嗪的结晶基
-
Application No.: US11816394Application Date: 2006-02-14
-
Publication No.: US07648991B2Publication Date: 2010-01-19
- Inventor: Benny Bang-Andersen , Heidi Lopez de Diego
- Applicant: Benny Bang-Andersen , Heidi Lopez de Diego
- Applicant Address: DK Valby-Copenhagen
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby-Copenhagen
- Agent Stephen G. Kalinchak
- International Application: PCT/DK2006/000088 WO 20060214
- International Announcement: WO2006/086986 WO 20060824
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; C07D241/04 ; C07D295/00
Abstract:
Crystalline base of compound trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, processes for the preparation of purified free base or salts of this compound, pharmaceutical compositions comprising the base and medical use thereof, including for treatment of schizophrenia and other psychotic disorders.
Public/Granted literature
- US20080153848A1 Crystalline Base of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine Public/Granted day:2008-06-26
Information query
